138 related articles for article (PubMed ID: 38389058)
1. Treatment effect estimation using the propensity score in clinical trials with historical control.
Kanamori S; Takeuchi M
BMC Med Res Methodol; 2024 Feb; 24(1):47. PubMed ID: 38389058
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
Wang X; Suttner L; Jemielita T; Li X
J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
[TBL] [Abstract][Full Text] [Related]
4. Dynamic use of historical controls in clinical trials for rare disease research: A re-evaluation of the MILES trial.
Harun N; Gupta N; McCormack FX; Macaluso M
Clin Trials; 2023 Jun; 20(3):223-234. PubMed ID: 36927115
[TBL] [Abstract][Full Text] [Related]
5. BASIC: A Bayesian adaptive synthetic-control design for phase II clinical trials.
Jiang L; Thall PF; Yan F; Kopetz S; Yuan Y
Clin Trials; 2023 Oct; 20(5):486-496. PubMed ID: 37313712
[TBL] [Abstract][Full Text] [Related]
6. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
Sawamoto R; Oba K; Matsuyama Y
Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
[TBL] [Abstract][Full Text] [Related]
7. Propensity score matched augmented controls in randomized clinical trials: A case study.
Lin J; Gamalo-Siebers M; Tiwari R
Pharm Stat; 2018 Sep; 17(5):629-647. PubMed ID: 30066459
[TBL] [Abstract][Full Text] [Related]
8. Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.
Brard C; Hampson LV; Gaspar N; Le Deley MC; Le Teuff G
BMC Med Res Methodol; 2019 Apr; 19(1):85. PubMed ID: 31018832
[TBL] [Abstract][Full Text] [Related]
9. Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls.
Yuan J; Liu J; Zhu R; Lu Y; Palm U
J Biopharm Stat; 2019; 29(3):558-573. PubMed ID: 30612514
[TBL] [Abstract][Full Text] [Related]
10. Confounding adjustment in the analysis of augmented randomized controlled trial with hybrid control arm.
Li L; Jemielita T
Stat Med; 2023 Jul; 42(16):2855-2872. PubMed ID: 37186394
[TBL] [Abstract][Full Text] [Related]
11. Causal inference for longitudinal data based on historical controls.
Liu J; Zhang J; Mitchell A; Fang M; Tian L
J Biopharm Stat; 2023 May; 33(3):289-306. PubMed ID: 36469552
[TBL] [Abstract][Full Text] [Related]
12. Covariate-adjusted borrowing of historical control data in randomized clinical trials.
Han B; Zhan J; John Zhong Z; Liu D; Lindborg S
Pharm Stat; 2017 Jul; 16(4):296-308. PubMed ID: 28560815
[TBL] [Abstract][Full Text] [Related]
13. Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials.
Ohigashi T; Maruo K; Sozu T; Gosho M
Stat Methods Med Res; 2022 Jul; 31(7):1392-1404. PubMed ID: 35379046
[TBL] [Abstract][Full Text] [Related]
14. Propensity Score: an Alternative Method of Analyzing Treatment Effects.
Kuss O; Blettner M; Börgermann J
Dtsch Arztebl Int; 2016 Sep; 113(35-36):597-603. PubMed ID: 27658473
[TBL] [Abstract][Full Text] [Related]
15. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.
Liu M; Bunn V; Hupf B; Lin J; Lin J
Stat Med; 2021 Sep; 40(22):4794-4808. PubMed ID: 34126656
[TBL] [Abstract][Full Text] [Related]
16. Propensity score-integrated power prior approach for augmenting the control arm of a randomized controlled trial by incorporating multiple external data sources.
Lu N; Wang C; Chen WC; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 Jan; 32(1):158-169. PubMed ID: 34756158
[TBL] [Abstract][Full Text] [Related]
17. A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis.
Yiu ZZN; Mason KJ; Barker JNWN; Hampton PJ; McElhone K; Smith CH; Warren RB; Griffiths CEM; Lunt M; Burden AD;
Br J Dermatol; 2019 Dec; 181(6):1265-1271. PubMed ID: 30822358
[TBL] [Abstract][Full Text] [Related]
18. Adaptive adjustment of the randomization ratio using historical control data.
Hobbs BP; Carlin BP; Sargent DJ
Clin Trials; 2013; 10(3):430-40. PubMed ID: 23690095
[TBL] [Abstract][Full Text] [Related]
19. Five Steps to Successfully Implement and Evaluate Propensity Score Matching in Clinical Research Studies.
Staffa SJ; Zurakowski D
Anesth Analg; 2018 Oct; 127(4):1066-1073. PubMed ID: 29324498
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
